tirzepatide vs. semaglutide vs Trial Results Post from Cleveland Clinic -

Retatrutide is the developmental designation for an investigational compound owned by Eli Lilly and Company

This treatment increases cellular turnover, assists with the release of comedones, decreases fine lines and wrinkles, evens skin tone and texture, and stimulates the production of collagen and elastin

Activation of these sensors initiates checkpoint cascades, most notably ATMChk2 and ATRChk1, which coordinate cell cycle arrest, DNA repair pathway selection and apoptosis or senescence when repair fails

This results in reduced inflammation, improved insulin sensitivity, and enhanced resilience to stress

Together with lifestyle modifications and regular monitoring, tirzepatide can play a vital role in promoting better heart health for those living with diabetes